Prospective Observational Study to Determine Kinetics of Procalcitonin in Hospitalized Children Receiving Antibiotic Therapy for Non-Critical Acute Bacterial Infections-Reference-Cited by-同舟云学术

Prospective Observational Study to Determine Kinetics of Procalcitonin in Hospitalized Children Receiving Antibiotic Therapy for Non-Critical Acute Bacterial Infections

Published:2020-10-16 Issue:1 Volume:10 Page:595-603
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Katz Sophie E.^ORCID,Crook Jennifer,McHenry Rendie,Szeles Andras,Halasa Natasha,Banerjee Ritu

Funder

bioMerieux

National Institute of Allergy and Infectious Diseases

Centers for Disease Control and Prevention

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-020-00358-7.pdf

Reference26 articles.

1. Gomez B, Mintegi S, Bressan S, Dalt LD, Gervaix A, Lacroix L, et al. Validation of the “step-by-step” approach in the management of young febrile infants. Pediatrics (Internet). 2016;138(2). https://pediatrics.aappublications.org/content/138/2/e20154381. Accessed 31 Mar 2020.

2. Kuppermann N, Dayan PS, Levine DA, Vitale M, Tzimenatos L, Tunik MG, et al. A clinical prediction rule to identify febrile infants 60 days and younger at low risk for serious bacterial infections. JAMA Pediatr. 2019;173(4):342–51.

3. de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16(7):819–27.

4. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004;363(9409):600–7.

5. Downes KJ, Fitzgerald JC, Schriver E, Boge CLK, Russo ME, Weiss SL, et al. Implementation of a pragmatic biomarker-driven algorithm to guide antibiotic use in the pediatric intensive care unit: the Optimizing Antibiotic Strategies in Sepsis (OASIS) II study. J Pediatric Infect Dis Soc. 2020;9(1):36–43.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HNL Dimer in plasma is a unique and useful biomarker for the monitoring of antibiotic treatment in sepsis;2023-08-28

2. Prognostic value of post-operative serum procalcitonin in gastric adenocarcinoma patients undergoing radical gastrectomy: propensity score matching analysis of extended cohort from a prospective bi-center study;Gastric Cancer;2023-08-14

3. Monitoring of sepsis by HNL Dimer in plasma and the comparison with current biomarkers;2023-07-13